Below is a summary of the full article. Click here for the full version or go back to LFC Live.net
Newcastle United has issued a significant ultimatum to striker Alexander Isak amid ongoing transfer speculation involving Liverpool. The club has made it clear that Isak must either accept an offer that meets their valuation of around £150 million ($201 million) or recommit professionally to Newcastle for the upcoming season. Newcastle recently rejected a £110 million ($147.8 million) bid from Liverpool, signaling their strong stance on the player's market value and their reluctance to sell for less than their desired price.
Isak, who is reportedly frustrated by Newcastle's refusal to let him leave this summer, has missed pre-season training due to a thigh injury and has been training separately from the main squad at the request of manager Eddie Howe. Howe expressed concern that Isak’s behavior should not adversely affect the rest of the team and maintained that there remains a path for Isak to return to Newcastle’s main group. However, reports suggest that the player has shown little interest in playing for Newcastle again if a move to Liverpool does not materialize.
Despite the tense situation, Isak is still under contract with Newcastle until 2028, giving the club strong leverage in negotiations and little pressure to agree to a sale. The timing is particularly notable with Liverpool set to visit Newcastle for a Premier League fixture on August 25. Until an acceptable offer arrives, Isak is expected to be sidelined, missing the Premier League opener against Aston Villa and possibly other early matches.
Overall, Newcastle’s ultimatum underscores their firm position: either a record transfer fee close to £150 million is accepted, or Isak must return to training and prepare to play for the club this season. Whether Liverpool will meet Newcastle’s asking price remains uncertain, leaving the Swedish striker's immediate future in doubt.
PP
For more news relating to Newcastle United, visit our sister site NUFC Latest Live.